March 14, 2018 / 3:30 AM / 9 months ago

BRIEF-Strides Shasun Gets U.S. FDA Approval For Efavirenz Tablet

March 14 (Reuters) - Strides Shasun Ltd:

* SAYS CO GETS U.S. FDA APPROVAL FOR EFAVIRENZ TABLET

* PRODUCT TO BE MANUFACTURED AT ORAL DOSAGE FACILITY AT BANGALORE; MARKETED BY STRIDES PHARMA INC IN U.S. MARKET Source text - bit.ly/2tKMrfZ Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below